Krakowska Akademia Neurologii Sp. z o.o.

Cracow 38 trials 16 recruiting

38 Registered trials

16 Currently recruiting

Organisation

Krakowska Akademia Neurologii Sp. z o.o.

Location

Cracow, Poland

Identifier

ORG-100046735

Address

Ul. Arianska 7/3, 31-505, Poland

Departments

-
616007: neurology
Centrum Neurologii Klinicznej
Krakowska Akademia Neurologii
N/A
N/D
NA
Neurology
Not applicable

Clinical trials at this site (38)

Search interface

A Study to Evaluate the Safety, Biomarkers, and Efficacy of Tominersen Compared With Placebo in Participants with Prodromal and Early Manife… Ended

2023-503928-10-00 Prodromal and Early Manifest Huntington’s Disease 4 2023-02-01
Safety and Efficacy of ALXN1720 in Adults with Generalized Myasthenia Gravis. Ended

2023-508284-77-00 Generalized Myasthenia Gravis with autoantibodies again 5 2022-11-16
A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients with Multiple Sclerosis Ended

2023-505974-14-00 Multiple Sclerosis (MS) 5 2022-06-23
A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants with Early Parkinson's Disease Ended

2023-507132-21-00 Early Parkinson's disease 10 2021-05-11
Inebilizumab efficacy and safety in adults with myasthenia gravis Ended

2023-510006-40-00 Myasthenia Gravis which is either due to acetylcholine 5 2021-03-22
An extension study to learn if Zilucoplan is safe and works over a long period in adult participants with generalized myasthenia gravis. Ended

2024-512399-37-00 Generalized Myasthenia Gravis 5 2020-12-29
An Open Label Extension Study of Ublituximab in Subjects with Relapsing Multiple Sclerosis Ended

2024-516680-91-00 relapsing multiple sclerosis 5 2020-05-21
A clinical study to investigate the efficacy, safety, and tolerability of continuous subcutaneous ND0612 infusion in comparison to oral trea… Ended

2024-511940-20-00 Parkinson's disease 5 2020-02-05
A Long Term Safety Study of ND0612 Administered as a Continuous SC Infusion in Advanced Parkinson’s Disease (BeyoND) Ended

2024-513548-27-00 Parkinson's disease 4 2016-10-05
Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in GBA-PD (ACTIVATE study) Ended

2022-501783-18-00 Parkinson’s Disease 4 2023-07-21
Phase 3 Study to Assess Efficacy and Safety of Batoclimab as Induction and Maintenance Therapy in Adult Participants with Generalized Myasth… Ended

2024-512258-91-00 Generalized Myasthenia Gravis (gMG) 5 2023-02-03
A clinical trial which runs in multiple countries and aims to evaluate the long-term safety and tolerability of the investigational product … Ended

2024-512123-37-00 Parkinson's disease 5 2021-05-27
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus) Ended

2023-506918-45-00 Mild cognitive impairment (MCI) or mild dementia, both 5 2021-05-17
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE) Ended

2023-506919-18-00 Mild cognitive impairment (MCI) or mild dementia, both 5 2021-05-17